Investment Summary

CCL Industries Invests In Acrus CCL Labels S.A.

On April 12, 2012, CCL Industries invested in beverage company Acrus CCL Labels S.A.

Investment Highlights
  • This is CCL Industries’ 1st transaction in the Beverages sector.
  • This is CCL Industries’ 1st transaction in Chile.

Investment Summary

Date 2012-04-12
Target Acrus CCL Labels S.A.
Sector Beverages
Investor(s) CCL Industries
Deal Type Stake Purchase

Target

Acrus CCL Labels S.A.

Santiago, Chile
Acrus CCL Labels S.A. designs and develops labels for wine and spirits market to other Spanish speaking countries in the Mercusor trading zone.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

CCL Industries

Toronto, Ontario, Canada

website


Category Company
Founded 1951
Sector Packaging
Employees25,100
Revenue 5.7B CAD (2021)
DESCRIPTION

CCL Industries specializes in label and packaging solutions for global corporations, small businesses and consumers. CCL Industries was incorporated in 1951 and is based in Toronto, Canada.


DEAL STATS #
Overall 3 of 41
Sector (Beverages) 1 of 1
Type (Stake Purchase) 1 of 2
Country (Chile) 1 of 1
Year (2012) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-04 Thunder Press

Batavia, Illinois, United States

Thunder Press, Inc. is a privately owned label company located near Chicago that operates under the trade name “Sertech.” Company manufactures inserts/outserts for the pharmaceutical industry.

Buy $10M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-17 Graphitype Printing - Pharmaceutical Division

Sydney, Australia

Graphitype Printing - Pharmaceutical Division is a privately owned printing company located near Sydney, Australia. The business produces labels and patient instructional leaflets for leading pharmaceutical customers in Australia and will complement the existing CCL Label Healthcare operation in Melbourne.

Buy AU$7M